Description
Cenforce (Sildenafil) 50 mg
Cenforce 50 mg is identified as a sildenafil tablet. Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor used for erectile dysfunction in adult men. The brand name Cenforce is not an official regulatory brand in the sources reviewed, so this summary focuses on the verified active ingredient, sildenafil.
Active Ingredient and Medicine Class
Active ingredient: sildenafil.
Medicine class: phosphodiesterase type 5 (PDE5) inhibitor. This class works by enhancing blood flow in the penis during sexual stimulation.
Established Medical Uses
Sildenafil is established for the treatment of erectile dysfunction in adult men. Regulatory labeling and clinical reviews describe its use as an oral therapy for this condition.
How It Works
Sildenafil inhibits PDE5, an enzyme that breaks down cyclic guanosine monophosphate (cGMP). By preserving cGMP in penile tissue, it helps relax smooth muscle and supports erections in response to sexual stimulation. It does not create an erection on its own.
Important Safety Information
Sildenafil must not be used with organic nitrates or organic nitrites because the combination can cause a dangerous fall in blood pressure. Sources also warn that sildenafil should be used carefully with alpha-blockers and with strong CYP3A4 inhibitors, which can increase sildenafil exposure and the risk of adverse effects. It is also not generally recommended for men for whom sexual activity is medically inadvisable because of cardiovascular status.
Possible Side Effects
Common adverse effects include headache, flushing, dyspepsia, nasal congestion, dizziness, back pain and abnormal vision. More serious reactions can include severe hypotension, hypersensitivity reactions, and prolonged or painful erections.
Scientific Evidence
Peer-reviewed reviews and meta-analyses show that sildenafil improves erectile function compared with placebo across multiple causes of erectile dysfunction. Published evidence also supports its overall tolerability, with most adverse effects being mild to moderate, while highlighting the clinically important nitrate interaction.
Medical Information Notice
This page is an educational summary based on sources available at the time of review and does not replace the official patient leaflet or assessment by a qualified healthcare professional.
Medical Sources
- U.S. Food and Drug Administration (FDA) — VIAGRA (sildenafil citrate) tablets, for oral use: Prescribing Information
- DailyMed / U.S. National Library of Medicine — SILDENAFIL tablets, for oral use: Prescribing Information
- Langtry HD, Markham A et al. — “Sildenafil: a review of its use in erectile dysfunction.” Drugs (1999). PubMed
